The new drug has already passed Phase 1 safety trials in humans, making it a "strong candidate" for future PTSD treatments.

A new study reveals that astrocyte-derived GABA, not neuronal activity, plays a central role in PTSD by impairing the brain’s ability to extinguish traumatic memories.

Excessive levels of GABA released by astrocytes impair the brain's ability to extinguish fear responses in PTSD, but a newly ...

Patients with post-traumatic stress disorder (PTSD) often struggle to forget traumatic memories, even long after the danger ...

Did you know that patients with post traumatic stress disorder (PTSD) often struggle to forget traumatic memories, even long after the danger has ...